Terms: = Breast cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
1237 results:
1. Incidence and survival of primary metastatic breast cancer in Denmark; implication of breast cancer screening, classification, and staging practice.
Berg T; Jensen MB; Rossing M; Axelsen CT; Kümler I; Søndergaard L; Vogsen M; Knoop AS; Ejlertsen B
Acta Oncol; 2024 May; 63():277-287. PubMed ID: 38711384
[TBL] [Abstract] [Full Text] [Related]
2. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
[TBL] [Abstract] [Full Text] [Related]
3. The effectiveness of couple-based interventions on the marital outcomes of women with genital and breast cancer and their partners: a systematic review and meta-analysis.
Zahedi H; Alizadeh-Dibazari Z; Mirghafourvand M; Sahebihagh MH; Hosseinzadeh M
BMC Cancer; 2024 Mar; 24(1):391. PubMed ID: 38539118
[TBL] [Abstract] [Full Text] [Related]
4. Women's attitudes and perspectives on the use of artificial intelligence in the assessment of screening mammograms.
Holen ÅS; Martiniussen MA; Bergan MB; Moshina N; Hovda T; Hofvind S
Eur J Radiol; 2024 Jun; 175():111431. PubMed ID: 38520804
[TBL] [Abstract] [Full Text] [Related]
5. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
6. IRE1 RNase controls cd95-mediated cell death.
Pelizzari-Raymundo D; Maltret V; Nivet M; Pineau R; Papaioannou A; Zhou X; Caradec F; Martin S; Le Gallo M; Avril T; Chevet E; Lafont E
EMBO Rep; 2024 Apr; 25(4):1792-1813. PubMed ID: 38383861
[TBL] [Abstract] [Full Text] [Related]
7. Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Santé cohort.
Sellem L; Srour B; Javaux G; Chazelas E; Chassaing B; Viennois E; Debras C; Druesne-Pecollo N; Esseddik Y; Szabo de Edelenyi F; Arnault N; Agaësse C; De Sa A; Lutchia R; Huybrechts I; Scalbert A; Pierre F; Coumoul X; Julia C; Kesse-Guyot E; Allès B; Galan P; Hercberg S; Deschasaux-Tanguy M; Touvier M
PLoS Med; 2024 Feb; 21(2):e1004338. PubMed ID: 38349899
[TBL] [Abstract] [Full Text] [Related]
8. Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors.
Koyuncu I; Temiz E; Güler EM; Durgun M; Yuksekdag O; Giovannuzzi S; Supuran CT
ChemMedChem; 2024 May; 19(9):e202300680. PubMed ID: 38323458
[TBL] [Abstract] [Full Text] [Related]
9. Age-related phenotypes in breast cancer: A population-based study.
Svanøe AA; Humlevik ROC; Knutsvik G; Sæle AKM; Askeland C; Ingebriktsen LM; Hugaas U; Kvamme AB; Tegnander AF; Krüger K; Davidsen B; Hoivik EA; Aas T; Stefansson IM; Akslen LA; Wik E
Int J Cancer; 2024 Jun; 154(11):2014-2024. PubMed ID: 38319154
[TBL] [Abstract] [Full Text] [Related]
10. Differential diagnosis of breast mucinous carcinoma with an oval shape from fibroadenoma based on ultrasonographic features.
Wang H; Hu Y; Tan C; Gu R; Li Y; Jin L; Jiang X; Mei J; Liu Q; Gong C
BMC Womens Health; 2024 Feb; 24(1):87. PubMed ID: 38310239
[TBL] [Abstract] [Full Text] [Related]
11. Targeting breast cancer with N-Acetyl-D-Glucosamine: Integrating Machine Learning and Cellular Assays for Promising Results.
Baysal Ö; Genç D; Silme RS; Kırboğa KK; Çoban D; Ghafoor NA; Tekin L; Bulut O
Anticancer Agents Med Chem; 2024; 24(5):334-347. PubMed ID: 38305389
[TBL] [Abstract] [Full Text] [Related]
12. Tumor microenvironment and immune system preservation in early-stage breast cancer: routes for early recurrence after mastectomy and treatment for lobular and ductal forms of disease.
Saad HA; Baz A; Riad M; Eraky ME; El-Taher A; Farid MI; Sharaf K; Said HEM; Ibrahim LA
BMC Immunol; 2024 Jan; 25(1):9. PubMed ID: 38273260
[TBL] [Abstract] [Full Text] [Related]
13. Biological Properties of Extracts Obtained from In Vitro Culture of
Kowalczyk T; Sikora J; Merecz-Sadowska A; Kukula-Koch W; Synowiec E; Majda A; Juda D; Śliwiński T; Sitarek P
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256118
[No Abstract] [Full Text] [Related]
14. Automated Versus Handheld breast Ultrasound for Evaluating Axillary Lymph Nodes in Patients With breast cancer.
Kim SM; Jang M; Yun B; Shin SU; Rim J; Kang E; Kim EK; Shin HC; Park SY; Kim B
Korean J Radiol; 2024 Feb; 25(2):146-156. PubMed ID: 38238017
[TBL] [Abstract] [Full Text] [Related]
15. Reconstruction of unreported subgroup survival data with PD-L1-low expression in advanced/metastatic triple-negative breast cancer using innovative KMSubtraction workflow.
Li Y; Liang X; Li H; Chen X
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212119
[TBL] [Abstract] [Full Text] [Related]
16. cd95 promotes stemness of colorectal cancer cells by lncRNA MALAT1.
Gao C; Jia K; Fang J; Zhu X; Hu J; Zhang Y; Jiang J; Yu X; Wang D; Gu H; Chen Z
Life Sci; 2024 Feb; 338():122394. PubMed ID: 38159593
[TBL] [Abstract] [Full Text] [Related]
17. Tubular Adenoma of the breast: Radiologic-Pathologic Correlation.
Joo GJ; Carter GJ; Berg WA
J Breast Imaging; 2023 Nov; 5(6):703-711. PubMed ID: 38141235
[TBL] [Abstract] [Full Text] [Related]
18. New Alternative Techniques for Sentinel Lymph Node Biopsy.
Subramonian S; Chopra S; Vidya R
Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138180
[No Abstract] [Full Text] [Related]
19. Body weight gain and control: beneficial effect of extra virgin olive oil versus corn oil in an experimental model of mammary cancer.
Moral R; Kapravelou G; Cubedo M; Solanas M; Escrich E
J Nutr Biochem; 2024 Mar; 125():109549. PubMed ID: 38104866
[TBL] [Abstract] [Full Text] [Related]
20. Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.
Cescon DW; Schmid P; Rugo HS; Im SA; Md Yusof M; Gallardo C; Lipatov O; Barrios CH; Perez-Garcia J; Iwata H; Masuda N; Otero MT; Gokmen E; Loi S; Haiderali A; Zhou X; Guo Z; Nguyen AM; Cortes J
J Natl Cancer Inst; 2024 May; 116(5):717-727. PubMed ID: 38070159
[TBL] [Abstract] [Full Text] [Related]
[Next]
